Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms

Archives of General Psychiatry

Volumn 57, Issue 5, 2000, Pages 471-480

  Sanfilipo, Michael ^a,b   Lafargue, Todd ^b,c   Rusinek, Henry ^b   Arena, Luigi ^a,b,c   Loneragan, Celia ^a,b   Lautin, Andrew ^a,b   Feiner, Deborah ^b   Rotrosen, John ^a,b   Wolkin, Adam ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BELLEVUE HOSPITAL CENTER   (United States)

^d Vet Admin NY Harbor Hlthcare S   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; FRONTAL LOBE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PREFRONTAL CORTEX; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER;

EID: 0034055508     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.5.471     Document Type: Article

References (69)

1. Ward KE, Friedman L, Wise A, Schulz SC. Meta-analysis of brain and cranial size in schizophrenia. Schizophr Res. 1996;22:197-213.
2. DeLisi LE, Sakuma M, Tew W, Knshner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129-140.
3. Gut RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gut RC. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145-152.
4. Zipursky RB, Lim KO, Sullivan EV, Brown BW. Pfefferbaum A Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 1992; 49:195-205.
5. Lim KO, Sullivan EV, Zipursky RB, Pfefferbaum A. Cortical gray matter volume deficits in schizophrenia: a replication. Schizophr Res. 1996;20:157-164.
6. Lauriello J. Hoff A, Wieneke MH, Blankfeld H, Faustman WO, Rosenbloom M, DeMent S. Sullivan EV. Lim KO, Pfefferbaum A. Similar extem of brain dysmorphology in severely ill women and men with schizophrenia. Am J Psychiatry. 1997; 154:819-825.
7. Sullivan EV, Lim KO, Mathalon D, Marsh L. Beal DM, Harris D, Hoff AL, Faustman WO, Pfefferbaum A. A profile of cortical gray matter volume deficits characteristic of schizophrenia. Cereb Codex. 1998;8:117-124.
8. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of magnetic resonance imaging studies. Br J Psychiatry. 1998; 172:110-120.
9. McCarley RW, Wible CG, Fmmin M, Hirayasu Y, Levitt JJ, Fisher IA, Shemon ME. MRI anatomy of schizophrenia. Biol Psychiatry. 1999;45:1099-1119.
10. Pearlson GD, Marsh L. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry. 1999;46:627-649.
11. Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry. 1996;153:1548-1553.
12. Zipursky RB, Lambe EK, Kaput S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry. 1998;55:540-546.
13. Breier A, Buchanan RW, Elksahef A, Munson RC, Kirkpatrick B. Gellad F, Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
14. Buchanan RW, Vladar K, Barta PE, Pearlson GD. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry. 1998;155:1049-1055.
15. Cannon TI, van Erp TGM, Huttunen M, Lonnqvist J, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG, Gut RC, Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenics patients, their siblings, and controls. Arch Gen Psychiatry. 1998;55:1084-1091.
16. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 1998;55:346-352.
17. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 1999;56:367-374.
18. Woodruff PW, McManus IC, David AS. Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry. 1995;58:457-461.
19. Tibbo P, Nopoulos P, Arndt S, Andreasen NC. Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry. 1999;44:405-412.
20. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 1996;53:425-436.
21. Akbarian S, Bunney WE, Jr, Potkin SG, Wigal SB, Haglnan JO, Sandman CA, Jones EG. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenic implies disturbances of cortical development. Arch Gen Psychiatry. 1993;50:169-177.
22. Akbarian S, Vinuela A, Kim JJ, Potldn SG, Bunney WEJ, Jones EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry. 1993;50:178-187.
23. Wolkin A, Rusinek H, Vaid G, Arena L, Lafargue T, Sanfilipo M, Loneragan C, Lautin A, Rotrosen J. Structural magnetic resonance image averaging in schizophrenia. Am J Psychiatry. 1998;155:1064-1073.
24. Wible CG, Shenton ME, Hokama H, Kikinis R, Jolesz FA, Metcalf D, McCarley RW. Prefrontal cortex and schizophrenia: a quantitative magnetic resonance imaging study. Arch Gen Psychiatry 1995;52:279-288.
25. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie ID, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry. 1992; 49:959-965.
26. Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, Cooper TB, Brodie ID, Laska E, Rotrosen JP. Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. Am J Psychiatry. 1996;153:346-354.
27. Sanfilipo M, Lafargue T, Arena L, Rusinek H, Kushner K, Lautin A, Loneragan C, Vaid G, Rotrosen J, Wolkin A. Fine volumetric analysis of the cerebral ventricular system in schizophrenia: further evidence for multifocal, mild-to-moderate enlargement. Schizophr Bull. 2000;26:201-216.
28. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R Patient Edition (SCID-P, version 1.0). Washington, DC: American Psychiatric Association; 1990.
29. Shtasel DL, Gur RE, Mozley D, Richards J, Taleff MM, Heimberg C, Gallacher F, Gur RC. Volunteers for biomedical research. Arch Gen Psychiatry. 1991;48:1022-1025.
30. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R Non-Patient Edition (SCID-NP, version 1.0). Washington, DC: American Psychiatric Association; 1990.
31. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, Md: National Institute of Mental Health; 1976. DHEW Publication ADM 76-338.
32. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962; 10:799-812.
33. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39:784-788.
34. Simpson GM, Angus JWS, A rating scale for extrapyramidal side effects. Acts Psychiatr Scandin Suppl. 1970;212:11-19.
35. Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Dept of Health, Education, and Welfare; 1976. Publication ADM 534-535 ed.
36. Tsui WH. MIDAS User's Manual (Version 0.6). Unpublished Manual from the Information Processing Laboratory, New York University Medical Center, New York, NY.
37. Rusinek H. Chandra R. Brain tissue volume measurement from magnetic resonance imaging: a phantom study. Invest Radiol. 1993;28:890-895.
38. Rusinek H, DeLeon MJ, George AE, Stylopoulos LA, Chandra R, Smith G, Rand T, Mourino M, Kowalski H. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology. 1991;178:109-114.
39. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med. 1992;327:604-612.
40. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lira KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994;51:874-887.
41. Oldfield RC. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia. 1971;9:97-113.
42. Flaum M, Swayze VW, O'leary DS, Yuh WT, Ehrhardt JC, Amdt SV, Andreasen NC. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry. 1995;152:704-714.
43. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence A Erlbaum Associates; 1988:92-92.
44. Pearlson GD. Superior temporal gyrus and planun temporale in schizophrenia: a selective review. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1203-1229.
45. Nelson MD, Saykin AJ, Flashinan LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 1998;55:433-440.
46. Velakoulis D, Pantelis C, McGorry PD, Dudgeon P, Brewer W, Cook M, Desmond P, Bridle N, Tierney P, Murrie V, Singh B, Copolov D. Hippocampal volume in first-episode psychoses and chronic schizophrenia. Arch Gen Psychiatry. 1999;56:133-140.
47. Woodruff PW, Phillips ML, Rushe T, Wright IC, Murray RM, David AS, Corpus callosum size and inter-hemispheric function in schizophrenia. Schizophr Res. 1999;23:189-196.
48. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry. 1993;150:59-65.
49. Buchsbaum MS, Tang CY Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998;9:425-430.
50. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 1999;122:593-624.
51. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit-based model of schizophrenia. Biol Psychiatry. 1999;45:17-25.
52. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: amorphometric analysis of prefrontal area 9 and occiptal area 17. Arch Gen Psychiatry. 1995;805-818.
53. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brain from schizophrenic patients: application of a three-dimensional. stereologic counting method. J Comp Neurol. 1998;392:402412.
54. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical detectors. Biol Psychiatry. 1993;34:768-772.
55. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215-224.
56. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophi Res. 1995;16:87-110.
57. Weinberber DR. On the plausibility of "the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology. 1996:14(suppl):1S-11S.
58. Berman KF, Weinberger DR. The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: in vivo physiological correlates of cognitive deficits. Progr Brain Res. 1990;85:521-537.
59. Friston KJ, Frith CD, Schizophrenia a disconnection syndrome? Clin Neurosci. 1995;3:89-95.
60. Friston KJ. The disconnection hypothesis. Schizophr Res. 1998:30:115-125.
61. McGuire PK, Frith CD. Disordered functional connectivity in schizophrenia. PsyChol Med. 1996;26:663-668.
62. Pearlson GD, Petty RG, Ross CA, Tien AY. Schizophrenia: a disease of heteromodal association cortex? Neuropsychopharmacology. 1996;14:1-17.
63. Pantelis C, Barnes TRE, Nelson HE. Is the concept of frontal-subcortical dementia relevant to schizophrenia? Br J Psychiatry. 1992;160:442-460.
64. Albert ML, Feldman RG, Willis AL. The "subcortical dementia" of progressive supranuclear palsy. J Neurol Heurosurg Psychiatry. 1974;37:121-130.
65. Cummings JL. Subcortical dementia: Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry. 1986;149:682-697.
66. Fenton WS, Wyatt RJ, McGlashan TH. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry. 1994;51:643-650.
67. Fuster JM. The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997.
68. Baare WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry 1999;45:1597-1605.
69. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.